ABSTRACT The presence of dominant transforming genes in human tumor cell lines has been investigated. High molecular weight DNAs isolated from celllines established from carcinomas and sarcomas ofvarious organs as well as from a glioblastoma and two melanomas were utilized to transfect NIH/3T3 mouse fibroblasts. The DNAs of T24 and A2182, two cell lines derived from a bladder and a lung carcinoma, respectively, and of HT-1080, a cell line established from a fibrosarcoma, were able to transform recipient NIH/3T3 cells. First-cycle transformants exhibited anchorage-independent growth and were tumorigenic in athymic and immunocompetent mice. Moreover, they contained human DNA sequences and were able to transmit their malignant phenotype in additional cycles of transfection. Southern blot analysis of T24-derived. transformants-showed that a single fragment of human DNA specifically cosegregated with the malignant phenotype, suggesting that it contained the T24 oncogene. Therefore, these human sequences were molecularly cloned with A Charon 9A as the cloning vector. The resulting recombinant DNA molecule, designated AT24-15A, was shown to contain a 15-kldobasepair EcoRI insert of human cellular DNA. AT24-15A DNA (either intact or EcoRI digested) transformed NIH/3T3 fibroblasts with a specific activity of20,000 focus-forming units per pmol of'cloned DNA. Our results indicate that we have molecularly cloned a biologically active oncogene present in T24 human bladder carcinoma cells.
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The origin of most human cancers remains unknown. A plausible theory predicts the existence of dominant genetic elements whose expression would be responsible for the onset of the neoplastic properties of tumor cells. The development of gene transfer and genetic engineering technologies has permitted the designing of experimental protocols to test such hypothesis (for reviews, see refs. 1 and 2). Transmission of the malignant phenotype from tumor to normal cells via transfection with discrete fragments of DNA provides direct evidence of the presence of dominant oncogenes in human tumor cells. Molecular cloning of these genes can then readily be achieved, provided that they are biochemically identified. Finally, characterization of these in vitro selected oncogenes will establish their role in the onset of human neoplasia.
Recently, several laboratories have been able to transform normal mouse cells with DNA isolated from various human tumor cell lines (3) (4) (5) (6) (7) . In this paper, we describe three additional human tumor cells whose malignant phenotype can be transmitted to normal cells via transfection of their respective high molecular weight DNA: T24, a cell line derived from a carcinoma of the urinary bladder (8); A2182, a cell line established from a lung carcinoma (S. A. Aaronson, personal communication); and HT-1080, a fibrosarcoma cell line (9) . In addition, we report here the isolation by molecular cloning techniques ofthe transforming gene of T24 human bladder carcinoma cells.
MATERIALS AND METHODS Cells. Human cell lines used in the present study are listed, along with their respective sources, in Table 1 . They were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calfserum. The NIH/3T3 fibroblasts (18) utilized in transfection assays (see below) were derived from a single clone (A6109) selected on the basis of its particularly flat morphology as well as by its low incidence of spontaneous overgrowth upon prolonged periods of incubation. Approximately 108 NIH/3T3 A6109 clonal cells were frozen in groups of 2 X 106 cells and periodically thawed so that, when used in transfection experiments, they had not been in culture for longer than 2 weeks:
Transfection Assays. We utilized the basic protocol of Wigler et aL (19) with minor modifications (20) . Approximately 30 ,tg of high molecular weight DNA in 1 ml of0.5 M CaCl2 was slowly added to 1 ml of250 mM Hepes, pH 7.1/1.5 mM sodium phosphate while a gentle stream of nitrogen was bubbled through. After formation ofthe calcium phosphate precipitate, this DNA solution was added to a 10-cm Petri dish in which 1.5 X 105 NIH/ 3T3 cells had been seeded the day before. After a 22-hr incubation, the DNA was removed and 10 ml fresh Dulbecco's modified Eagle's medium containing 5% calfserum was added. Foci were counted 2 weeks later in an attempt to avoid scoring secondary foci that formed as a consequence of cell spread. Transformed cells were collected by the cloning cylinder procedure and transferred to soft agar (0.3%) plates, and individual colonies were selected for further characterization.
Analysis of Clonal Transformed Cells. DNA isolated from representative clones was subjected to Southern blot analysis (21) for detection of human marker sequences. Twenty micrograms of each DNA was digested with appropriate restriction endonucleases according to the conditions suggested by the manufacturer. Digested DNA was applied to 0.6% horizontal agarose gels, electrophoresed at 30 V for 20 hr, blotted to nitrocellulose sheets, and hybridized for 48 hr to 2 X 107 cpm of the corresponding nick-translated 32P-labeled DNA.
Molecular Cloning. The Charon 9A strain of A phage was propagated in Escherichia coli K-12 DP50 sup F (22) . DNA was purified from CsCl-banded phage as described (23) . EcoRI (Table  1 ). These DNAs were tested for their ability to induce. morphologic transformation upon transfection of NIH/3T3 mouse cells. The efficiency of our transfection assays was monitored by using a DNA extracted from K-HOS, a human cell line transformed by the Kirsten strain of murine sarcoma virus (17 Shih et al. (3) in which a probe for a family of highly repeated human sequences [designated "Alu sequences" (26) ] was used to identify human DNA on a murine genomic background. First-cycle transformants derived from T24, HT-1080, or A2182 human cells contained a large number of DNA fragments that hybridized to a probe representative for the human Alu repetitive sequences (Fig. 1) . None of these fragments was detected in control NIH/3T3 DNA, indicating that they were derived from the transfecting human DNA.
Proc., Nad Acad Sci.' USA 79 (1982) Hybridized blots were exposed to Kodak XR-5 film at -70°C in the presence of intensifier screens for 2 days. Coelectrophoresed DNA fragments of Hindm-digested A c1857 DNA served as size standards (labeled in kilobase pairs).
A Single T24-Derived Human DNA Fragment Cosegregates with the Malignant Phenotype. The large fraction ofdonor DNA incorporated by transfection-competent NIH/3T3 cells (27) hampered the identification of those human DNA sequences harboring the transforming gene(s). However, cotransfected, nongenetically linked human sequences should be eliminated in subsequent cycles of transfection. Therefore, DNAs from representative transformants were used to transform NIH/ 3T3 cells in an effort to identify biochemically those sequences encompassing human transforming genes. Second-cycle transformants derived from T24 cells possessed one or two high molecular weight human DNA fragments as deduced from their ability to hybridize with a probe for human Alu marker sequences (Fig. 2) . Only one of these DNA fragments was found to cosegregate with the transformed phenotype after an additional (third) cycle oftransfection, indicating that the T24 transforming gene must be contained within these human sequences. When similar experiments were performed with transformants derived from A2182 and HT-1080 cells, several human DNA fragments were found to cosegregate with the transformed phenotype even after three cycles of transfection. These results suggest that the transforming genes ofA2182 and HT-1080 human tumor cell lines must have a larger genetic complexity than that present in T24 bladder carcinoma cells.
Molecular Cloning of the T24 Oncogene. For molecular cloning of the T24 oncogene in a biologically active form, we selected a second-cycle transformant, designated 44-91, that contains a single human DNA fragment known to cosegregate with the transformed phenotype (see Fig. 2, lanes a-c) . In addition, it was necessary to find a restriction endonuclease that would be compatible with available cloning vectors but would not inactivate the transforming activity of 44-91 DNA or physically separate the T24 oncogene from the human Alu marker sequences. Among those enzymes tested (Table 2) , BamHI, EcoRI, and HindIII did not affect the biologic activity of 44-91 DNA. Moreover, NIH/3T3 transformants obtained with either EcoRI-or HindIII-digested 44-91 DNA retained the human Alu sequences (Fig. 2, lanes d-g) , making these two enzymes suitable for the molecular cloning of the T24 oncogene. The fact that transformants generated with BamHI-cleaved DNA lacked such marker sequences suggested that they are not an integral part of the T24 transforming gene (Fig. 2, lanes h and  i) . EcoRI-digested 44-91 was partially purified by sucrose gradient centrifugation in an effort to enrich for sequences of human origin. Fractions hybridizing to a human Alu probe were ligated to EcoRI-cleaved DNA purified from the Charon 9A strain of A phage (22) , packaged in vitro into phage particles, and plated onto E. coli K-12 LE392. Of the 5 x 105 plaques obtained, -50% were found to be recombinant phages as determined by hybridization with a 32P-labeled NIH/3T3 DNA High molecular weight DNA was incubated with the indicated restriction endonucleases according to the conditions recommended by the manufacturer. Digested DNA was extracted with 1 vol of phenol and then with 1 vol of chloroform:isoamyl alcohol, 24:1 (vol/vol). De- proteinized DNA was precipitated with ethanol, resuspended in distilled water, and used for transfecting 1.5 x 105 NIH/3T3 cells seeded the previous day in 10-cm Petri dishes (usually four plates per experiment and DNA). Foci were scored after 14 days of cultivation. probe. Of these, only one plaque hybridized to a 32P-labeled human DNA probe. This phage was plaque-purified three times, grown to mass culture, and further characterized. This recombinant phage, designated AT24-15A, contained a 15-kilobase-pair EcoRI insert that replaced the 6.9-and 5.7-kilobasepair EcoRI internal fragments of A Charon 9A (Fig. 3) . The human, rather than mouse, origin of this cloned 15-kilobase-pair EcoRI insert was demonstrated by the presence of human-specific Alu sequences (Fig. 3) and by its lack of hybridization to mouse cellular DNA (Fig. 4, lane c) we transfected NIH/3T3 cells with varying amounts of AT24-15A DNA. As little as 1 ng of this recombinant DNA molecule induced morphologic transformation ofrecipient cells (Table 3) . Cleavage of AT24-15A DNA with EcoRI prior to transfection slightly enhanced its biological activity, yielding a transforming specific activity of -20,000 focus-forming units per pmol of cloned human insert. When representative NIH/3T3 transformants were picked and grown to mass culture, their DNA was found to contain those human sequences present in AT24-15A recombinant DNA (Fig. 4, lanes a and b) . These results, taken together, demonstrate that we have cloned a DNA fragment that contains a biologically active human oncogene present in T24 bladder carcinoma cells.
DISCUSSION
The ability of human tumor cell lines to transmit their neoplastic properties to normal cells would support the concept that they contain dominant oncogenes. Previous studies have shown that inoculation into rats of cells established from various human tumors induced the formation of sarcomas of host rather than of human origin (28) . Recently, DNAs isolated from cell lines derived from several types of human tumors have been found to transform mouse fibroblasts in in vitro transfection assays (3) (4) (5) (6) (7) . In the present study we have shown that DNA isolated from three additional human cell lines derived from bladder and lung carcinomas and from a fibrosarcoma were able to transmit their malignant phenotype to NIH/3T3 cells. These findings not only provide evidence for the presence of transmissible oncogenes in human tumor cell lines but also indicate that such oncogenes are not restricted to cells derived from a particular type of neoplasia.
Emerging evidence indicates that oncogenes present in different human tumor cell lines have an independent genetic origin. For instance, second-cycle transformants derived from human cell lines established from various tumors including bladder and colon carcinomas, a neuroblastoma, and a myeloid leukemia exhibited different restriction enzyme patterns of human Alu marker sequences (6, 7) . Similarly, we have found that restriction enzymes such as BamHI, EcoRI, or HindIII which do not inactivate the T24 oncogene completely abolish transformation induced by HT-1080 DNA (unpublished data). Nevertheless, Perucho et aL (7) have reported that oncogenes present in human cell lines derived from a colon and two lung carcinomas may be identical or at least closely related. In similar studies, Lane et al. (5) observed that the transforming activities of DNAs isolated from human and mouse mammary tumor cell lines were equally affected by digestion with several restriction endonucleases. Thus, it is possible that only a limited number of oncogenes are responsible for the appearance of at least certain types of naturally occurring tumors.
The ubiquitous presence ofcertain repetitive (Alu) sequences in mammalian genomes, along with their highly evolved nature (26) , has made it possible to detect human DNA fragments biochemically in a murine genetic background (3, 6, 7) . Cosegregation of any of these fragments with malignant transformation induced by human tumor DNAs served as a criterion for the identification ofthose sequences encompassing the corresponding human oncogenes. A combination of these experimental approaches has allowed us to clone molecularly the transforming gene of T24 human bladder carcinoma cells. In fact, it should be possible to apply a similar protocol to the isolation of any biologically detectable human oncogene with only the limitations imposed by current recombinant DNA technology (i.e., gene size, poisonous sequences, etc.). Characterization of the cloned T24 oncogene not only should provide definitive evidence regarding its genetic nature but, more importantly, it also should enable us to elucidate its involvement in bladder carcinomas as well as in other types of human malignancies.
Note Added in Proof. We have shown that the transforming sequences of the T24 bladder carcinoma oncogene are located within an internal 6.6-kilobase-pair BamHI fragment of XT24-15A. Moreover, in collaborative studies with S. Tronick and S. A. Aaronson, we have found that this fragment contains sequences related to the onc gene of BALB murine sarcoma virus and closely resembles the normal human analogue of this retroviral onc gene.
